The verdictThe evidence leans bearish for the next 12 months. Q2 extraction fell to ~41k lb, every pound delivered in Q2 cost $84.99 against a $73.00 sale price, and unrestricted cash was $21.8M against a ~$21M quarterly operating burn. A $250M ATM, bigger than the company's ~$180M market value, is the obvious bridge. The assets are real and the stock trades at ~0.8x book, but unless Texas permits arrive in Q4 2026 to Q1 2027…
Written by Claude (Anthropic’s AI) from public sources · Willem owns EU · AI can make mistakes — numbers in brackets point to the sources · Not financial advice
Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).
| Quarter | Extraction | Basis |
|---|---|---|
| Q2 2025 | ~243,900 lb | derived |
| Q3 2025 | 227,070 lb | stated |
| Q4 2025 | ~155,100 lb | derived |
| Q1 2026 | 90,000 lb | stated |
| Q2 2026 | ~41,300 lb | derived |
| Date | 2027 commitment |
|---|---|
| 2025-12-31 | 850k lb |
| 2026-03-31 | 925k lb |
| 2026-06-30 | 1,045k lb |
| Company | Latest output / cost | Balance sheet |
|---|---|---|
| UEC (FY to Jul-26) | 229,294 lb; Q4 rose to 82,744 lb; cash cost $34.24 | $495M cash, $753M liquid, no debt [23] |
| Ur-Energy (Q2) | record 140,873 lb drummed; cash cost $40.20 | $95.3M cash [25] |
| Boss | Honeymoon FY27 guide 1.25–1.30M lb | debt-free, A$207M liquid [16] |
| enCore | ~41k lb in Q2; total delivered cost $75.54 | $21.8M cash, $115M convertible [2,3] |
Consensus FY2026 is $69.0M revenue and EPS −$0.41 (6 analysts) [30]. FY2027 consensus is unverified: aggregators range from $85M to $130M. EPS is negative, so impacts below use pre-tax free cash flow per share (194.3M shares). enCore has tax losses, so pre-tax roughly equals post-tax.
Texas permits arrive on schedule and 2027 extraction rebounds to ≥500k lb — 30% chance by end-2027
New term contracts at ≥$90/lb replace legacy ceilings — 28% chance by end-2027
US government purchase of US-origin uranium includes enCore — 9% chance of an award by end-2028
Takeover bid at a premium (Boss, a larger ISR player or a utility/fund) — 14% chance within 36 months
ATM dilution of ≥20% within 18 months at around $1 — 65% chance
TCEQ slips again, pushing first new-wellfield pounds into H2 2027 — 40% chance
Spot rises above ~$100 while 2027 buy-ins are needed — 30% chance in 2027
Nasdaq deficiency notice and reverse split — 35% chance within 12 months
Dewey-Burdock licence or state permits delayed beyond 2028 — 45% chance
Class-action settlement — 25% chance of a cash settlement within 24 months
| # | Factor | Weight | Measured value | Score | Why |
|---|---|---|---|---|---|
| 1 | Liquidity & funding runway | 15% | $21.8M unrestricted cash vs |
78 | Under 12 months without new equity, but there is no going-concern language and a $250M ATM is in place. |
| 2 | Leverage | 10% | $115M 5.5% convertible due 2030-08; net debt ~$61M (estimate: debt minus cash and marked securities); EBITDA negative; no covenants, no maturity before 2030 | 72 | Large debt against negative EBITDA, but long-dated and covenant-free, so it sits below the >5x band. |
| 3 | Dilution | 10% | Shares 187.4M (2025-12-31) → 194.3M (+3.7%); overhang: ATM ≈270M shares at $0.92 (139%), convertible 35.0M (18%, out of the money), options and RSUs ~11.9M (6%) | 75 | Realised dilution is modest, but the ATM alone exceeds the share count. |
| 4 | Profitability | 10% | Gross margin −0.3% (Q1), −16.4% (Q2); operating margin −188% (Q2); FCF margin −122% (Q1), −141% (Q2) | 85 | Deep losses with no improvement until permits arrive. |
| 5 | Revenue quality & concentration | 10% | Top customer 63% of 2025 revenue, top 3 99%; one producing site (Alta Mesa) plus purchased pounds; 14 multi-year utility contracts | 72 | Above 35% for the top customer and a single asset, partly offset by contracted, recurring sales. |
| 6 | Execution & track record | 10% | ICFR material weakness 2024 → 06-2026 unremediated; permit dates missed (Mar "final roadblock", Q3 disposal well); Dewey-Burdock 18 months → 2028; no numeric guidance; cost figures differ between release and 10-K | 85 | Serial misses plus a material weakness. |
| 7 | Competitive position & disruption | 10% | Total delivered cost $75.54/lb vs UEC $34 and Ur-Energy $40 cash cost; smallest balance sheet; but 4 of 13 US ISR plants built and licensed | 65 | Losing ground to funded peers; the plants are still a scarce asset. |
| 8 | Cyclicality & commodity/macro sensitivity | 10% | One commodity (U3O8); 8 of 14 contracts have floors; net buyer today, so higher prices hurt in the short run | 68 | Highly exposed to one commodity, but the floors and the contract book mean survival hinges on permits, not on price. |
| 9 | Regulatory, legal & geopolitical | 5% | Single Texas regulator (3 pending authorisations plus a licence renewal under review since 2024); NRC hearing Dec 2026 / Jan 2027; 8th Circuit case; class action; former-COO arbitration | 70 | Large pending rulings, but none is existential. |
| 10 | Valuation & expectations | 10% | P/B ~0.8 vs peers 1.2–5.8x; EV ~$4.70 per resource lb; short interest 19.8% of float, 4.3 days to cover; targets $1.44–3.75 vs $0.92 | 52 | Cheap on assets, but heavy short interest and stale targets around a fragile story offset that. |
Overall: weighted average = 0.15×78 + 0.10×72 + 0.10×75 + 0.10×85 + 0.10×72 + 0.10×85 + 0.10×65 + 0.10×68 + 0.05×70 + 0.10×52 = 72.6 → 73.
Change vs last: +5 vs 68, which used the old 6-area method, so the delta is partly a method change. On substance:
Ranking check: At 73, enCore sits level with SHAZ (73) and just above GRRR (72). It has real revenue, book value above its price and no debt due before 2030, so it is less exposed to dilution than SHAZ (Class A shares more than tripled) and GRRR (2027 convertible reset). It ranks equal or higher because its cash need is immediate, it loses money on every pound it sells, and its whole recovery waits on one regulator's decision.